Indocyanine green dye enhanced laser photocoagulation for juxtafoveal choroidal neovascularisation.

Purpose: To evaluate the initial results of pilot study of indocyanine green dye enhanced laser photocoagulation for juxtafoveal choroidal neovascularisation (CNV).
Materials and Methods: The study was conducted on eleven eyes of 11 patients of CNV during the period 2001 and 2002. Two to three minutes after the injection of 5 ml of 25 mgm of indocyanine green (ICG) dye, 810 nm diode laser was used to treat the choroidal neovascular lesions.
Results: The age of the patients ranged from 45 to 80 years. All patients completed 12 months of follow-up. Eight eyes (72.7%) had neovascular age related macular degeneration, 2 eyes (18.2%) had myopic CNV and one eye (9.09%) had CNV secondary to angioid streak. The presenting visual acuity was <or=6/60 in seven, 6/36 in one and >or=6/12 in three patients. The final visual acuity at the end of at least 12 months follow-up was 6/12 or better in one eye (9%); 6/18-6/36 in 3 eyes (27.27%) and <or=6/60 in 7 eyes (63.64%). In four patients the vision improved whereas it worsened or remained same in 7 eyes.
Conclusion: ICG dye enhanced diode laser photocoagulation appears to be a potential option for juxtafoveal CNV.